Healthcare and Life Science
Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards for the treatment of Crohn’s disease, it has emerged. ...
Qkine wins ‘Scale-up of the Year’ at the 2024 Cambridge Independent Business Awards
On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the Cambridge Independent Business awar...
AstraZeneca unveils The Hub, a new amenities centre, on Cambridge Biomedical Campus
AstraZeneca has today officially opened The Hub in Cambridge, a purposely designed amenities centre, where employees and the local community can collaborate, socialise and unwind. Located at the heart of the Cambridge Biomedical Campus (CBC), The Hub offers a wide range of facilities ...
Human skin map gives 'recipe' to build skin and could help prevent scarring
For the first time, researchers have created a single cell atlas of prenatal human skin to understand how skin forms, and what goes wrong in disease. ...
Leadership change at CMR Surgical
CMR Surgical, the global surgical robotics business, announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board. ...
New lab to open to make cutting-edge CAR-T cells in Cambridge
A new state-of-the-art laboratory is set to open at Addenbrooke’s Hospital that will deliver ‘home-grown’ CAR-T cells to help improve treatment for blood cancers. ...
Lily Lin visits Gluetacs Therapeutics
On 15th October 2024, Lily Lin, CEO of Excellence First Enterprise Consultancy, accompanied by Iris Li and Yang Qing from the Lingang Cambridge Network (LCN), visited Gluetacs Therapeutics, a pioneering biotech company and LCN member. Dr. Yang, the founder of Gluetacs, along with his ...
Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases
The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones. ...
Stevenage Bioscience Catalyst scoops the Most Successful Science Park (Small) Award at UKSPA40 Anniversary Awards
Congratulations to everyone who took part and for a fantastic and insightful conference from UKSPA, The United Kingdom Science Park Association. Dr Sally Ann Forsyth OBE, CEO of SBC, said: “Stevenage Bioscience Catalyst is truly honoured to win Most Successful Science Park (Small) Aw...
Cambridge reveals innovation blueprint to become world’s leading science and tech region
With the aim to achieve the same level of innovation in the next 10 years as the last 25 years. ...